The state of Mississippi currently has 2 active clinical trials seeking participants for Diabetic Macular Edema research studies. These trials are conducted in various cities, including Jackson, Tupelo, Hattiesburg and Flowood.
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
NCT05610319
Recruiting
This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/14/2024
Locations: Mississippi Retina Associates, Jackson, Mississippi
Conditions: Diabetic Macular Edema
Register for Updates
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
NCT06011798
Recruiting
The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Edema. The main questions the study aims to answer are: Assess the efficacy of foselutoclax compared to aflibercept Assess the safety and tolerability of foselutoclax
Gender:
All
Ages:
18 years and above
Trial Updated:
05/03/2024
Locations: Deep Blue Retina Clinical Research, PLLC, Southaven, Mississippi
Conditions: Diabetic Macular Edema, Retinal Disease, Macular Edema, Diabetes Mellitus, Diabetic Retinopathy, Retinal Degeneration, Retinal Diseases, Eye Diseases, Edema
Register for Updates